LBX Pharmacy Chain JSCSHSE:603883 +1.33%71 ROE % is 15.83% as of Mar. 2026, which is 9% above its 10-year median of 14.58. GuruFocus rates SHSE:603883 with a GF Score™ of 71/100 and a GF Value™ of ¥19.19 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 623 Healthcare Providers & Services companies, LBX Pharmacy Chain JSC ranks worse than 50.24% on this metric.
The historical rank and industry rank for LBX Pharmacy Chain JSC's ROE % or its related term are showing as below:
SHSE:603883'
s ROE % Range Over the Past 10 Years
Min: 5.82 Med: 14.58 Max: 16.2
Current: 5.86
During the past 13 years, LBX Pharmacy Chain JSC's highest ROE % was 16.20%. The lowest was 5.82%. And the median was 14.58%.
SHSE:603883's ROE % is ranked worse than 50.24% of 623
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs SHSE:603883: 5.86
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, LBX Pharmacy Chain JSC's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LBX Pharmacy Chain JSC ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LBX Pharmacy Chain JSC's ROE % distribution charts can be found below:
* The bar in red indicates where LBX Pharmacy Chain JSC's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
LBX Pharmacy Chain JSC (SHSE:603883) has a ROE % of 15.83% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on LBX Pharmacy Chain JSC and its competitors. This is near median its historical median of 14.58. Over the past decade, LBX Pharmacy Chain JSC's ROE % has ranged from 5.82 to 16.20. According to the industry distribution chart, LBX Pharmacy Chain JSC ranks #313 out of 623 companies in the Healthcare Providers & Services industry, placing it in the top 50.2%.
Is LBX Pharmacy Chain JSC's ROE % too high?
LBX Pharmacy Chain JSC's current ROE % of 15.83% is near median its 10-year median of 14.58. Over the past 10 years, this metric has ranged from a low of 5.82 to a high of 16.20. The Healthcare Providers & Services industry median ROE % is 5.88. LBX Pharmacy Chain JSC's value of 15.83% is 169.2% above this industry median. Based on the distribution chart, LBX Pharmacy Chain JSC ranks #313 out of 623 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 71/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's ROE % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, LBX Pharmacy Chain JSC ranks #313 out of 623 companies for ROE %. This places LBX Pharmacy Chain JSC in the lower half of its industry. The industry median ROE % is 5.88. LBX Pharmacy Chain JSC's value of 15.83% is 169.2% above this benchmark. Historically, LBX Pharmacy Chain JSC's own ROE % has ranged from 5.82 to 16.20 over the past decade. While the company's 10-year median is 14.58 vs. the industry median of 5.88, LBX Pharmacy Chain JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 623 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LBX Pharmacy Chain JSC's current ROE % of 15.83% is 169.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on LBX Pharmacy Chain JSC and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LBX Pharmacy Chain JSC's current ROE % is 15.83%, which is near median its own 10-year median of 14.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.19, compared to a current price of ¥11.41 — trading 40.5% below its estimated fair value. The current ROE % is 15.83%, which is near median its 10-year median of 14.58 and 169.2% above the Healthcare Providers & Services industry median of 5.88. LBX Pharmacy Chain JSC's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current ROE % is 15.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥11.41 is trading 40.5% below its estimated GF Value™ of ¥19.19.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
ROE %: 15.83% (near median its 10-year median of 14.58)
GF Value™: ¥19.19 vs. price of ¥11.41 (40.5% below fair value)
Industry Position: 169.2% above the Healthcare Providers & Services median (#313 of 623)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
71GF Score
Get the complete analysis for SHSE:603883
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
